Plan: OPEN | Option: Growth | Meeta Shetty

23 Sep 22 | 12:00 AM

16.27 -0.09 (-0.53%)

  • Outperforms

    -10.65%

    Return (1Y)

    beaten Nifty Pharma TRI by 0.96%

  • Less Volatile

    0.93%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.26%

  • Consistent

    7/12

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • Tata India Pharma & Healthcare Fund (G) fund has been the 3rd best in 5Y performance in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been given the 3rd best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been the 2nd best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (G), has beaten by 0.96% (CAGR difference)

-10.65%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (G) is Lower than by -0.26%

0.93%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 7 out of Last 12 Months, i.e 58.33% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition